Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Trends in Parasitology|February 22, 2023
Ivermectin and moxidectin against soil-transmitted helminth infectionsEveline Hürlimann, Daniela Hofmann, Jennifer Keiser
Journal of the American Chemical Society|December 2, 2017
Activity of Tumor Necrosis Factor α Is Modulated by Dynamic Conformational RearrangementsDaniela Hofmann, Loïc Salmon, Gerhard Wider
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 3, 2021
Development and validation of an LC-MS/MS method for the quantification of the anthelmintic drug moxidectin in a volumetric absorptive microsample, blood, and plasma: Application to a pharmacokinetic study of adults infected with Strongyloides stercoralis in LaosDaniela Hofmann, Somphou Sayasone, Jennifer Keiser
Journal of Biomolecular NMR|December 7, 2011
Sugar-to-base correlation in nucleic acids with a 5D APSY-HCNCH or two 3D APSY-HCN experimentsBarbara Krähenbühl, Daniela Hofmann, Christophe Maris, et al.
ACS Infectious Diseases|September 29, 2020
Characterization of Moxidectin against <i>Strongyloides ratti</i>: In Vitro and In Vivo Activity and Pharmacokinetics in the Rat ModelValentin Buchter, Daniela Hofmann, Cécile Häberli, et al.
Clinical and Translational Science|December 10, 2021
Optimizing moxidectin dosing for Strongyloides stercoralis infections: Insights from pharmacometric modelingDaniela Hofmann, Cornelis Smit, Somphou Sayasone, et al.
Clinical Pharmacokinetics|July 23, 2021
Characterization of the Population Pharmacokinetics of Moxidectin in Adults Infected with Strongyloides Stercoralis: Support for a Fixed-Dose Treatment RegimenCornelis Smit, Daniela Hofmann, Somphou Sayasone, et al.
The Lancet. Infectious Diseases|April 2, 2021
Efficacy and safety of ascending doses of moxidectin against Strongyloides stercoralis infections in adults: a randomised, parallel-group, single-blinded, placebo-controlled, dose-ranging, phase 2a trialDaniela Hofmann, Somphou Sayasone, Khanpaseuth Sengngam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 16, 2020
Efficacy and Safety of Albendazole in Hookworm-infected Preschool-aged Children, School-aged Children, and Adults in Côte d'Ivoire: A Phase 2 Randomized, Controlled Dose-finding TrialChandni Patel, Jean T Coulibaly, Daniela Hofmann, et al.
The Journal of Antimicrobial Chemotherapy|February 13, 2022
Pharmacokinetic modelling and simulation to optimize albendazole dosing in hookworm- or Trichuris trichiura-infected infants to adultsDaniela Hofmann, Janneke M Brussee, Jessica D Schulz, et al.
Pageof 3